<div id="readability-page-1"><p>H. B. Fuller (NYSE:FUL - Get Free Report) is expected to announce its  Q4 2025 results after the market closes on Wednesday, January 14th. Analysts expect H. B. Fuller to post earnings of $1.24 per share and revenue of $901.34 million for the quarter. H. B. Fuller has set its FY 2022 guidance at $4.100-$4.350 EPS. Investors may visit the the company's upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, January 15, 2026 at 10:30 AM ET.</p><ul><li>Industrial Chemicals: 3 Stocks Poised for Growth in the New Year</li></ul><p>H. B. Fuller (NYSE:FUL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 13th. The specialty chemicals company reported $0.66 earnings per share for the quarter. The business had revenue of $725.90 million for the quarter. H. B. Fuller had a net margin of 3.28% and a return on equity of 11.49%.  On average, analysts expect H. B. Fuller to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year. </p><h2>H. B. Fuller Stock Performance</h2><p>Shares of NYSE FUL opened at $61.64 on Wednesday. The firm has a fifty day moving average price of $58.69 and a 200-day moving average price of $59.45. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.93 and a quick ratio of 1.18. The stock has a market cap of $3.33 billion, a PE ratio of 33.32, a price-to-earnings-growth ratio of 0.97 and a beta of 1.10. H. B. Fuller has a 1 year low of $47.56 and a 1 year high of $65.36. </p><h2>Insider Buying and Selling</h2><ul><li>Acuity Brands Lights Up Opportunity In The Industrial Sector </li></ul><p>In related news, VP Nathan D. Weaver sold 7,075 shares of the business's stock in a transaction on Thursday, November 13th. The shares were sold at an average price of $58.38, for a total value of $413,038.50. Following the sale, the vice president owned 9,441 shares in the company, valued at approximately $551,165.58. The trade was a 42.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO John J. Corkrean sold 14,222 shares of the company's stock in a transaction on Monday, October 27th. The shares were sold at an average price of $60.31, for a total transaction of $857,728.82. Following the sale, the chief financial officer directly owned 54,646 shares in the company, valued at approximately $3,295,700.26. The trade was a 20.65% decrease in their position. The SEC filing for this sale provides additional information. Insiders own  1.99% of the company's stock. </p><h2>Institutional Trading of H. B. Fuller</h2><p>Large investors have recently made changes to their positions in the business. Quantinno Capital Management LP boosted its stake in  H. B. Fuller by 137.3% during the second quarter. Quantinno Capital Management LP now owns 9,929 shares of the specialty chemicals company's stock worth $597,000 after buying an additional 5,745 shares during the period.  Cerity Partners LLC raised its stake in shares of  H. B. Fuller by 2.3% in the second quarter. Cerity Partners LLC now owns 11,499 shares of the specialty chemicals company's stock valued at $692,000 after acquiring an additional 261 shares during the period.  Baird Financial Group Inc. lifted its holdings in shares of  H. B. Fuller by 19.6% in the 2nd quarter. Baird Financial Group Inc. now owns 7,518 shares of the specialty chemicals company's stock worth $452,000 after acquiring an additional 1,232 shares during the last quarter.  Vise Technologies Inc. bought a new stake in shares of  H. B. Fuller in the 3rd quarter worth about $254,000.  Finally, Mercer Global Advisors Inc. ADV purchased a new position in shares of  H. B. Fuller during the 3rd quarter worth about $229,000. 95.93% of the stock is currently owned by institutional investors. </p><h2>Analyst Ratings Changes</h2><ul><li>Dividend King H.B. Fuller Rises On Hopes For Rebound</li></ul><p>Several research analysts recently weighed in on the stock. Wall Street Zen downgraded shares of H. B. Fuller from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Monday, November 24th. Seaport Res Ptn raised H. B. Fuller from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Friday, September 26th. Weiss Ratings  reiterated a &#34;hold (c)&#34; rating on shares of H. B. Fuller in a research report on Monday, December 29th. Citigroup raised H. B. Fuller from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and lifted their target price for the company from $62.00 to $70.00 in a research note on Wednesday, October 22nd. Finally, UBS Group started coverage on H. B. Fuller in a research note on Friday, November 21st. They issued a &#34;neutral&#34; rating and a $60.00 price target for the company. Two analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, two have given a Hold rating and one  has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $66.20.</p><p><b>Check Out Our Latest Stock Report on H. B. Fuller</b></p><h2>About H. B. Fuller</h2> (Get Free Report)<p>H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.  </p><p>Fuller's product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than H. B. Fuller</li><li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li><li>Do not delete, read immediately</li><li>A U.S. “birthright” claim worth trillions - activated quietly</li><li>This stock gets a 94 out of 100</li><li>BNZI: BNZI Surges Ahead as AI Marketing Fuels Record Revenue</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZVTA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUZVTA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in H. B. Fuller Right Now?</h2><p>Before you consider H. B. Fuller, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and H. B. Fuller wasn't on the list.</p><p>While H. B. Fuller currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>H. B. Fuller (NYSE: FUL) is set to release its Q4 2025 earnings on January 14, with analysts expecting earnings of $1.24 per share and revenue of $901.34 million. The company has provided FY 2022 guidance of $4.100-$4.350 EPS. Recent insider trading includes sales by VP Nathan D. Weaver and CFO John J. Corkrean. Institutional investors hold 95.93% of the stock, with recent changes in positions by several firms. Analyst ratings have varied, with some upgrades and downgrades noted.</p>

H. B. Fuller (FUL) to Release Quarterly Earnings on Wednesday